Canada authorises use of Pfizer/BioNTech anti-Covid vaccine booster

Oct 08, 2022, at 08:32 pm

Ottawa/IBNS: Health Canada Friday authorised the use of a Pfizer/BioNTech COVID-19 vaccine booster targeting Omicron sub variants.

Canada adds another weapon against Covid19

Oct 08, 2022, at 05:11 pm

Ottawa/IBNS: Health Canada Friday authorized the use of a Pfizer/BioNTech COVID-19 vaccine booster targeting Omicron sub variants.

Moderna sues Pfizer, BioNTech alleging patent infringement over Covid vaccine

Aug 27, 2022, at 02:38 am

Washington/IBNS: Moderna Friday announced to sue its suing rival vaccine makers Pfizer and BioNTech, alleging the partners infringed on its patents in developing their Covid-19 shot, which was administered to hundreds of millions around the world.

India won't buy 'expensive' Moderna, Pfizer Covid-19 shots as local production soars: Report

Sep 22, 2021, at 03:40 am

New Delhi/IBNS: India would not buy Covid-19 vaccines from foreign producers  Pfizer/BioNTech and Moderna as domestic production of the shots has increased manifold, Reuters reported citing sources.

Pfizer-BioNTech apply for US authorization to use Its vaccine in adolescents : Statement

Apr 10, 2021, at 04:08 pm

Washington/Sputnik: Pfizer and BioNTech said in a statement that they have applied to expand emergency use authorization of their vaccine for usage in adolescents between 12 and 15 years old.

Pfizer- BioNTech seek permission for emergency use of Covid-19 vaccine in adolescents in US

Apr 10, 2021, at 06:11 am

Washington/IBNS: US drug major Pfizer Inc and its German partner BioNTech SE have sought the permission for emergency use of their vaccine in adolescents aged 12 to 15, according to a Reuters report.

BioNTech-Pfizer claims COVID-19 vaccine 100 percent effective on 12-15 years olds

Mar 31, 2021, at 10:52 pm

New York: Pfizer Inc. and BioNTech SE on Wednesday announced that, in a Phase 3 trial in adolescents 12 to 15 years of age with or without prior evidence of SARS-CoV-2 infection, the Pfizer-BioNTech COVID-19 vaccine BNT162b2 demonstrated 100% efficacy and robust antibody responses, exceeding those recorded earlier in vaccinated participants aged 16 to 25 years old, and was well tolerated.

Bahrain approves Pfizer-BioNTech vaccine against Covid-19

Dec 05, 2020, at 04:26 pm

Manama/IBNS: Bahrain became the second country in the world to approve an emergency use of the vaccine against Covid-19 developed by US pharmaceutical giant Pfizer and its German partner BioNTech.

India's Covid-19 tally crosses 95 lakh with over 35,000 new cases in 24 hours

Dec 03, 2020, at 04:21 pm

New Delhi/IBNS: India's Novel Coronavirus tally on Thursday crossed 95 lakh with the reporting of over 35,000 new infections in the last 24 hours.